RGX-104,610318-54-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

RGX-104

CAS No. : 610318-54-2

MCE 国际站：RGX-104

产品活性：RGX-104 是具有口服生物活性的、有效的肝X核激素受体 (LXRβ) 激动剂，通过 ApoE 基因的转录激活调节先天免疫。

研究领域：Metabolic Enzyme/Protease  |  Vitamin D Related/Nuclear Receptor

作用靶点：LXR

In Vivo: Oral administration of RGX-104 (100 mg/kg, daily) to animals bearing palpable tumors significantly suppresses the growth of multiple cancer types. Co-administration of RGX-104 with anti-PD-1 is superior to administration of either RGX-104 or anti-PD-1 alone. Importantly, co-administration of RGX-104 with anti-PD-1 therapy is well tolerated by mice, with no overt signs of toxicity.

相关产品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Orally Active Compound Library  |  Lipid Metabolism Compound Library   |  Targeted Diversity Library  |  Nuclear Receptor Compound Library  |  T0901317  |  GW3965 hydrochloride  |  GSK2033  |  27-Hydroxycholesterol  |  LXR-623  |  SR9243  |  (20S)-Protopanaxatriol  |  SR9238  |  Saikosaponin A  |  DMHCA  |  24-Hydroxycholesterol  |  AZ876  |  XL041  |  GSK3987  |  Larsucosterol (trimethylamine)  |  BMS-779788  |  RGX-104 hydrochloride  |  Rovazolac  |  IMB-808  |  Acetyl podocarpic acid anhydride  |  FITC-GW3965  |  GW6340  |  Nagilactone B  |  Yamogenin  |  22(R)-Hydroxycholesterol  |  BE1218  |  GAC0001E5  |  GAC0003A4

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds